Hematology/Oncology

Top Story

Self-reported Agent Orange exposure higher among veterans with thyroid cancer

Self-reported Agent Orange exposure higher among veterans with thyroid cancer
February 11, 2016

Self-reported Agent Orange exposure was more prevalent among patients with thyroid cancer compared with the overall national Veterans Affairs patient population, study results show.

Angela M. Leung, MD, MSc, assistant professor of medicine in the division of endocrinology at UCLA David Geffen School of Medicine and VA Greater Los Angeles Healthcare System, and colleagues evaluated data from all U.S. Veterans Health Administration health care sites from October 1999 to 2013 to determine the characteristics of patients with thyroid cancer in relation to Agent Orange exposure. Overall, 19,592 patients with thyroid cancer were included in the study.

In the Journals

Radiology guidelines have reduced variability in lung cancer screening strategies

February 11, 2016
Most leading U.S. academic medical centers use the same radiology guidelines and nodule threshold criteria within their lung cancer screening practices since the…
Meeting News Coverage

Top Takeaways from ASH: ELOQUENT-2 trial results of elotuzumab demonstrate immune effects

February 11, 2016
Updated results of the ELOQUENT-2 trial – a phase 3, randomized, open-label study – presented at the ASH Annual Meeting and Exposition focused on 3-year…
In the Journals

Hyperthyroidism increases breast cancer risk

February 11, 2016
Women with hyperthyroidism have an increased risk for breast cancer, whereas there was a slightly decreased risk among women with hypothyroidism, according to study…
In the Journals

High ligand expression predicts panitumumab benefit for RAS wild-type colorectal cancer

February 11, 2016
High epiregulin and amphiregulin expression levels appeared to serve as a predictive biomarker for PFS benefit from panitumumab therapy in patients with RAS wild-type…
More News Headlines »
CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Video

VIDEO: Increase in cancer among younger patients requires vigilant screening techniques

January 27, 2016
More »
Featured
CME

The Patient with Non-Small Cell Lung Cancer

No commercial support for this activity.

The management of non-small cell lung cancer (NSCLC) has evolved in the past decade, as advances are made in diagnosis…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan morganatic-roan